Sanofi secures exclusive rights to develop plozasiran in Greater China, enhancing treatment options for hypertriglyceridemia ...

Following the discontinuation of ALLO-647 due to a treatment-related death, Allogene will move forward with a streamlined ...

Medipost transitioned from cord blood banking to developing stem cell therapies, focusing on knee osteoarthritis and other ...

Computational chemistry combined with AI technologies has become a powerful tool for assessing small molecule properties, ...

Organizations commonly navigate outdated systems that make collaboration harder and breakthroughs slower, causing delays, ...